For instance, the combinations of sPD-L1 with PD-L1 in tumor cells [128] or PD-L1 positivity in tumor tissues [18] were more beneficial in assessing the postoperative prognosis and the OS of patients with NSCLC or ccRCC. This evidence concerns the gene SPDL1 and nonpapillary renal cell carcinoma.